SCHEMBL12347516

SCHEMBL12347516

O=C(O)c1ccccc1C(=O)c1ncc(Cl)cc1NSc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 3/20 0.41
▸ CLCN2 P51788 1/20 0.41
▸ GRIK1 P39086 1/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ GRM4 Q14833 1/20 0.37
▸ CCR2 P41597 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CCR4 P51679 1/20 0.36
▸ CCR5 P51681 1/20 0.36
▸ LTC4S Q16873 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ KIT P10721 2/20 0.35
▸ BRAF P15056 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ FLT3 P36888 2/20 0.35
▸ NOTUM Q6P988 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12347487 0.90 CYP2C9 (0.41) CYP2C9CYP3A4GRM4CCR2KDM4E
SCHEMBL14302510 0.85 CYP2C9 (0.39) CYP2C9CLCN2CYP3A4GRM4CCR2
SCHEMBL14303613 0.84 CYP2C9 (0.43) CYP2C9CYP3A4GRM4CCR2GLA
SCHEMBL307486 0.80 CYP2C9 (0.63) CYP2C9CYP3A4CCR2CYP1A2CYP2D6
SCHEMBL14310292 0.79 CDK8 (0.40) CYP2C9GRM4KITBRAFKDR
SCHEMBL13958200 0.77 BRAF (0.49) CYP2C9CYP3A4CCR2KITBRAF
SCHEMBL306010 0.75 CYP2C9 (0.46) CYP2C9CYP3A4CCR2CYP1A2CYP2D6
SCHEMBL12593777 0.74 AURKA (0.51) CYP2C9CLCN2KDM4EKDR
SCHEMBL12347533 0.73 KDM4E (0.49) CYP2C9GRM4HPGDCYP1A2CYP2D6
SCHEMBL14303603 0.73 NR4A1 (0.48) CYP2C9GRIK1CYP3A4CCR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2354126-A1 Heteroaryl sulfonamides and CCR2 ChemoCentryx, Inc. (US) 2011-08-10 — — EP disclosed
Send feedback